AOP Health Receives Market Authorization for Landiolol in Canada
- ICU
- 13/12/2023
AOP Health Receives Market Authorization for Landiolol in Canada
READ MOREAOP Health Receives Market Authorization for Landiolol in Canada
READ MOREPlanned EU Pharmaceutical Legislation Could Complicate Development of Rare Disease Therapies
READ MOREBlood Cancer: AOP Health Announces New Findings in Patients with Polycythemia Vera
READ MOREIntroducing Hamilton Medical's VenTrainer - A Mobile Application Redefining Ventilation Training
READ MORECollaborative Research Ensures Availability of Rare Disease Therapies
READ MOREFapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
READ MOREMasimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
READ MOREGetinge Completes Acquisition of High Purity New England, Inc.
READ MOREFDA Clears Nova’s Stat Profile Prime Plus Analyzer for Micro Capillary Sample Mode
READ MOREWorld Sepsis Day: Understanding Symptoms Better
READ MORE